Related Experiment Video
Updated: May 15, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events,
Soo Ting Toh1, Yu Jin, Lizhen Liu
1Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Insights
Hepatitis B virus (HBV) integration in hepatocellular carcinoma (HCC) tumors shows specific patterns, including preferential insertion into gene promoters and the TERT gene, potentially driving cancer development. This study reveals HBV
Area of Science:
- Virology
- Oncology
- Genetics
Background:
- Chronic hepatitis B virus (HBV) infection is linked to hepatocellular carcinoma (HCC), but the underlying mechanisms are unclear.
- Technological limitations have hindered a comprehensive understanding of HBV's role in HCC development.
Purpose of the Study:
- To systematically characterize HBV integration and alterations in HCC tumors.
- To identify specific host and viral genomic regions involved in HBV integration and structural changes.
Main Methods:
- Enrichment of HBV sequences from 48 HCC patients using an oligo-bead-based strategy.
- High-throughput sequencing (FLX-Genome-Sequencer) of pooled HBV DNA.
- Analysis of HBV integration sites, viral structural alterations, and gene expression (TERT).
Main Results:
- HBV preferentially integrates into gene promoters (P < 0.001), with significant enrichment on chromosome 10 (P < 0.01).
- Integration into chromosome 10 correlates with poorly differentiated HCC (P < 0.05).
- Recurrent HBV integration into the TERT promoter increases TERT expression, and alterations often involve the 3'-end of the HBx gene, leading to chimeric transcripts and proteins.
Conclusions:
- HBV exhibits high mutability and specific integration preferences in HCC.
- HBV integration into host genes, particularly TERT, and viral structural alterations are key events in HCC pathogenesis.
- Understanding these HBV-host interactions provides insights into HCC development and potential therapeutic targets.
Abstract:
Chronic hepatitis B virus (HBV) infection is epidemiologically associated with hepatocellular carcinoma (HCC), but its role in HCC remains poorly understood due to technological limitations. In this study, we systematically characterize HBV in HCC patients. HBV sequences were enriched from 48 HCC patients using an oligo-bead-based strategy, pooled together and sequenced using the FLX-Genome-Sequencer. In the tumors, preferential integration of HBV into promoters of genes (P < 0.001) and significant enrichment of integration into chromosome 10 (P < 0.01) were observed. Integration into chromosome 10 was significantly associated with poorly differentiated tumors (P < 0.05). Notably, in the tumors, recurrent integration into the promoter of the human telomerase reverse transcriptase (TERT) gene was found to correlate with increased TERT expression. The preferred region within the HBV genome involved in integration and viral structural alteration is at the 3'-end of hepatitis B virus X protein (HBx), where viral replication/transcription initiates. Upon integration, the 3'-end of the HBx is often deleted. HBx-human chimeric transcripts, the most common type of chimeric transcripts, can be expressed as chimeric proteins. Sequence variation resulting in non-conservative amino acid substitutions are commonly observed in HBV genome. This study highlights HBV as highly mutable in HCC patients with preferential regions within the host and virus genome for HBV integration/structural alterations.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Mechanisms of Retrovirus-induced Cancers

